ImmunoGen Inc (IMGN)

US45253H1014 - Common Stock

31.23  0 (0%)

After market: 31.24 +0.01 (+0.03%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
287.70M108.80M69.90M132.30M82.30M
Cost Of Goods
3.90M200.00KN/AN/AN/A
Gross Profit
283.70M108.60MN/AN/AN/A
Operating Expenses
363.90M329.50M194.90M153.20M153.00M
Research and Development
207.80M213.40M151.10M114.60M114.50M
Selling, General, and Administrative Expenses
156.20M116.10M43.80M38.60M38.50M
Operating Income
-80.20M-220.90M-125.10M-20.90M-70.80M
Interest Income/Expense
7.10M200.00K-13.10M-22.50M-12.60M
Other Income/Expense
500.00K-1.00M-1.10M500.00K600.00K
Non Recurring Items
N/AN/A0.00-1.50M-21.40M
Income Before Taxes
-72.60M-221.70M-139.30M-44.40M-104.10M
Income Tax
N/A1.20MN/AN/AN/A
Net Income
-73.50M-222.90M-139.30M-44.40M-104.10M
EBITDA
-78.48M-219.12M-123.08M-18.80M-66.77M
 
Per Share Data
EPS Diluted Total Ops
-0.30-0.88-0.68-0.25-0.70
Non GAAP EPS
-0.31-0.88-0.67-0.28-0.71
 
Statistics
Gross Profit Margin
98.61%99.82%N/AN/AN/A
Profit Margin
-25.55%-204.87%-199.28%-33.56%-126.49%
Operating Profit Margin
-27.88%-203.03%-178.97%-15.80%-86.03%

All data in USD

Charts